Publications by authors named "Elizabeth J Jackson"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

2,478

Total Likes

182

Extended Reach

237,464

Social Features

110
L
LDL cholesterol management simplified in adults-Lower for longer is better: Guidance from the National Lipid Association.
Elizabeth J Jackson, Kaye-Eileen Willard, Christie M Ballantyne

J Clin Lipidol· June 2025

Videos about Article: user user

2 1 4 107 2

View All Article and Social Media Activity
L
Lipidology: The time is now for specialty recognition.
Kaye-Eileen Willard, Don P Wilson, Elizabeth J Jackson, Carol F Kirkpatrick, Mary Katherine Cheeley

J Clin Lipidol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The importance of low-density lipoprotein cholesterol measurement and control as performance measures: A joint Clinical Perspective from the National Lipid Association and the American Society for Preventive Cardiology.
Salim S Virani, Karen Aspry, Dave L Dixon, Keith C Ferdinand, Paul A Heidenreich, Elizabeth J Jackson

J Clin Lipidol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The importance of low-density lipoprotein cholesterol measurement and control as performance measures: A joint clinical perspective from the National Lipid Association and the American Society for Preventive Cardiology.
Salim S Virani, Karen Aspry, Dave L Dixon, Keith C Ferdinand, Paul A Heidenreich, Elizabeth J Jackson

Am J Prev Cardiol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipid measurements in the management of cardiovascular diseases: Practical recommendations a scientific statement from the national lipid association writing group.
Peter W F Wilson, Terry A Jacobson, Seth S Martin, Elizabeth J Jackson, N-Anh Le

J Clin Lipidol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing Optimized Treatment Plans for Patients with Dyslipidemia in the Era of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Therapeutics.
James A Underberg, Michael J Blaha, Elizabeth J Jackson, Peter H Jones

Am J Med· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis